Hepatitis B
Teresa M. Wozniak A , Mitchell Smith B and Lisa Maher C
+ Author Affiliations
- Author Affiliations
A NSW Public Health Officer Training Program, NSW Ministry of Health
B Centre for Population Health, NSW Ministry of Health
C Centre for Immunology, Kirby Institute
NSW Public Health Bulletin 24(2) 94-94 https://doi.org/10.1071/NB12094
Published: 7 November 2013
References
[1] O'Sullivan BG, Gidding HF, Law M, Kaldor JM, Gilbert GL, Dore GJ. Estimates of chronic hepatitis B virus infection in Australia, 2000. Aust N Z J Public Health 2004; 28 212–6.| Estimates of chronic hepatitis B virus infection in Australia, 2000.Crossref | GoogleScholarGoogle Scholar | 15707165PubMed |
[2] Dienstag JL. Hepatitis B virus infection. N Engl J Med 2008; 359 1486–500.
| Hepatitis B virus infection.Crossref | GoogleScholarGoogle Scholar | 1:CAS:528:DC%2BD1cXhtFOru7bL&md5=f9cf2929d1f38cb471c2492210dbebe2CAS | 18832247PubMed |
[3] Deacon RM, Topp L, Wand H, Day CA, Rodgers C, Haber PS, et al. Correlates of susceptibility to hepatitis B among people who inject drugs in Sydney, Australia. J Urban Health 2012; 89 769–78.
| 22684422PubMed |
[4] Australian Government Department of Health and Ageing. National Hepatitis B Strategy 2010–2013. Commonwealth of Australia; 2010. Available at: http://www.health.gov.au/internet/main/publishing.nsf/Content/ohp-national-strategies-2010-hepb/$File/hepb.pdf (Cited July 2012).
